Investigators tested whether ligand-independent activation of EphA2 modulated chemoresistance by enhancing stemness in SCLC.
[Cancer Science]
Home Newsletters Ligand-Independent EphA2 Contributes to Chemoresistance in Small-Cell Lung Cancer by Enhancing PRMT1-Mediated...
